Last reviewed · How we verify
Administration of drugs concomitantly. — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Administration of drugs concomitantly. (Administration of drugs concomitantly.) — HaEmek Medical Center, Israel.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Administration of drugs concomitantly. TARGET | Administration of drugs concomitantly. | HaEmek Medical Center, Israel | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Administration of drugs concomitantly. CI watch — RSS
- Administration of drugs concomitantly. CI watch — Atom
- Administration of drugs concomitantly. CI watch — JSON
- Administration of drugs concomitantly. alone — RSS
Cite this brief
Drug Landscape (2026). Administration of drugs concomitantly. — Competitive Intelligence Brief. https://druglandscape.com/ci/administration-of-drugs-concomitantly. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab